Filtered By:
Specialty: Health Management
This page shows you your search results in order of date. This is page number 14.
Order by Relevance | Date
Total 916 results found since Jan 2013.
Healthcare resource utilization and costs of cardiovascular events in patients with atherosclerotic cardiovascular disease in Germany - results of a claims database study
CONCLUSION: CV events in ASCVD patients pose a considerable clinical burden on patients and cause significant costs for the German statutory healthcare system.PMID:36330899 | DOI:10.1080/13696998.2022.2141964
Source: Journal of Medical Economics - November 4, 2022 Category: Health Management Authors: Eduard Sidelnikov Eugen Dornstauder Christian Jacob Christopher Maas Lionel Pinto Reiner Leidl Ingo Ahrens Source Type: research
Evaluation of the Million Hearts ® Cardiovascular Disease Risk Reduction Model
In this model, CMS pays participating organizations for assessing each of their eligible Medicare beneficiary ' s risk of having a heart attack or stroke over the next 10 years and for reducing CVD risk among high-risk beneficiaries.
Source: RAND Research Health and Health Care - October 25, 2022 Category: Health Management Authors: Greg Peterson; Alli Steiner; Rhea Powell; Julia Rollison; Amanda Markovitz; Laura Blue; Kate Stewart; Dan Kinber; Rachel Kogan; Danielle Whicher; Rui Wang; Jia Pu; Keith Kranker; Malcolm V. Williams; Nancy McCall; Alex Bryce; Liisa Hiatt; Elizabeth H Source Type: research
Measurement properties and interpretability of the PROMIS item banks in stroke patients: a systematic review
ConclusionThe PROMIS Global Health showed sufficient structural and construct validity and internal consistency in stroke patients. There is a need for further research on content validity, structural validity, and measurement invariance of PROMIS measures in stroke patients.Trial Registration Information: CRD42020203044 (PROSPERO).
Source: Quality of Life Research - October 22, 2022 Category: Health Management Source Type: research
Formulary restrictions and stroke risk in patients with atrial fibrillation
CONCLUSIONS: Limiting access to NOACs may exacerbate current underuse of anticoagulants and increase the risk of stroke among patients with newly diagnosed AF. Pharmacy benefit managers and Part D plans need to continuously review the appropriateness of formulary policies to ensure patient access to effective medications.PMID:36252171 | DOI:10.37765/ajmc.2022.89195
Source: The American Journal of Managed Care - October 17, 2022 Category: Health Management Authors: Bo Zhou Seth Seabury Dana Goldman Geoffrey Joyce Source Type: research
